{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:14:50Z","timestamp":1790874890503,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008680","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.rmed.2021.106436","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:43:15Z","timestamp":1620078195000},"page":"106436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-1345","authenticated-orcid":false,"given":"Ogugua Ndili","family":"Obi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athol U.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-2977(98)00058-8","article-title":"Clinical presentation of sarcoidosis in The Netherlands an epidemiological study","volume":"53","author":"Wirnsberger","year":"1998","journal-title":"Neth. J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2021.106436_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000092670","article-title":"Relationship between symptoms and quality of life in a sarcoidosis population","volume":"74","author":"Michielsen","year":"2007","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.rmed.2021.106436_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0030-1262216","article-title":"Quality of life in sarcoidosis: assessment and management","volume":"31","author":"De Vries","year":"2010","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2021.106436_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/resp.12359","article-title":"The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis","volume":"19","author":"de Boer","year":"2014","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.rmed.2021.106436_bib5","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","article-title":"Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis","volume":"102","author":"Gvozdenovic","year":"2008","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib6","first-page":"43","article-title":"Exercise and resting pulmonary function in sarcoidosis","volume":"13","author":"Karetzky","year":"1996","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thx.2004.022244","article-title":"Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status","volume":"60","author":"Spruit","year":"2005","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib8","first-page":"148","article-title":"Impaired exercise response in sarcoid patients with normal pulmonary functio","volume":"19","author":"Delobbe","year":"2002","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib9","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2021.106436_bib10","first-page":"2","article-title":"Patient reported outcome measures (PROMs) in sarcoidosis","volume":"34","author":"Thunold Rf","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.rmed.2021.106436_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1378\/chest.120.1.102","article-title":"Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis","volume":"120","author":"Baydur","year":"2001","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2021.106436_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.78.4.640","article-title":"Use of pulmonary function tests in the management of sarcoidosis","volume":"78","author":"Winterbauer","year":"1980","journal-title":"Chest"},{"issue":"5147","key":"10.1016\/j.rmed.2021.106436_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.2.5147.257","article-title":"The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population","volume":"2","author":"Fletcher","year":"1959","journal-title":"Br. Med. J."},{"key":"10.1016\/j.rmed.2021.106436_bib15","series-title":"Committee on Research into Chronic Bronchitis. Instructions for the Use of the Questionnaire on Respiratory Symptoms","author":"National Health","year":"1966"},{"issue":"6","key":"10.1016\/j.rmed.2021.106436_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/occmed\/kqx086","article-title":"The MRC breathlessness scale","volume":"67","author":"Williams","year":"2017","journal-title":"Occup. Med. (Lond.)"},{"issue":"5","key":"10.1016\/j.rmed.2021.106436_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med. Sci. Sports Exerc."},{"issue":"6","key":"10.1016\/j.rmed.2021.106436_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejim.2006.02.024","article-title":"Quality of life in patients with active sarcoidosis in Greece","volume":"17","author":"Antoniou","year":"2006","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","article-title":"Six-minute walk test and health status assessment in sarcoidosis","volume":"132","author":"Baughman","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2021.106436_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/2049-6958-5-3-202","article-title":"Measures of dyspnea in pulmonary rehabilitation","volume":"5","author":"Crisafulli","year":"2010","journal-title":"Multidiscip Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2021.106436_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2021.106436_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rmed.2021.106436_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0761-8425(09)72424-6","article-title":"[Validation study of the BDI\/TDI scores in chronic obstructive pulmonary disease]","volume":"26","author":"Laurendeau","year":"2009","journal-title":"Rev. Mal. Respir."},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1207\/s15327558ijbm0202_3","article-title":"Reliability and validity of dyspnea measures in patients with obstructive lung disease","volume":"2","author":"Eakin","year":"1995","journal-title":"Int. J. Behav. Med."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/COPD-200050666","article-title":"The MCID of the transition dyspnea index is a total score of one unit","volume":"2","author":"Mahler","year":"2005","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.rmed.2021.106436_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0895-4356(02)00589-9","article-title":"Meaningful effect size and patterns of response of the transition dyspnea index","volume":"56","author":"Witek","year":"2003","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.rmed.2021.106436_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3109\/15412555.2012.701678","article-title":"Longitudinal changes in patient-reported dyspnea in patients with COPD","volume":"9","author":"Mahler","year":"2012","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.rmed.2021.106436_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1378\/chest.121.3.688","article-title":"Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation","volume":"121","author":"Aaron","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1378\/chest.102.2.395","article-title":"Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease","volume":"102","author":"Mahler","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1164\/ajrccm.151.1.7812573","article-title":"Changes in dyspnea, health status, and lung function in chronic airway disease","volume":"151","author":"Mahler","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib31","first-page":"19","article-title":"Assessment instrument investigators, the WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"8","key":"10.1016\/j.rmed.2021.106436_bib32","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Pt 3","key":"10.1016\/j.rmed.2021.106436_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS)","volume":"9","author":"De Vries","year":"2004","journal-title":"Br. J. Health Psychol."},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib34","first-page":"133","article-title":"Psychometric qualities of the fatigue assessment scale in Croatian sarcoidosis patients","volume":"22","author":"Michielsen","year":"2005","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"issue":"Suppl B","key":"10.1016\/j.rmed.2021.106436_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St george's respiratory questionnaire","volume":"85","author":"Jones","year":"1991","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2021.106436_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2021.106436_bib38","first-page":"71","article-title":"[St. George's respiratory questionnaire (SGRQ) in sarcoidosis patients]","volume":"58","author":"Zugi\u0107","year":"2005","journal-title":"Med. Pregl."},{"issue":"5","key":"10.1016\/j.rmed.2021.106436_bib39","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0040-1710080","article-title":"Health-related quality of life in sarcoidosis","volume":"41","author":"Obi","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2021.106436_bib40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients - appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"issue":"47","key":"10.1016\/j.rmed.2021.106436_bib41","article-title":"Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: a cross-sectional study","volume":"95","author":"Chuang","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.rmed.2021.106436_bib42","first-page":"58","article-title":"Ventilatory disturbances in patients with intrathoracic sarcoidosis - a study from a functional and histological perspective","volume":"34","author":"Calaras","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2021.106436_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-10-67","article-title":"Distance saturation product predicts health-related quality of life among sarcoidosis patients","volume":"10","author":"Bourbonnais","year":"2012","journal-title":"Health Qual. Life Outcome"},{"issue":"4","key":"10.1016\/j.rmed.2021.106436_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000079641","article-title":"Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis","volume":"71","author":"Barros","year":"2004","journal-title":"Respiration"},{"issue":"12","key":"10.1016\/j.rmed.2021.106436_bib45","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/rheumatology\/kep284","article-title":"Minimally important differences in the mahler's transition dyspnoea index in a large randomized controlled trial--results from the scleroderma lung study","volume":"48","author":"Khanna","year":"2009","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rmed.2021.106436_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","article-title":"Minimal important difference of the transition dyspnoea index in a multinational clinical trial","volume":"21","author":"Witek","year":"2003","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:37:51Z","timestamp":1760618271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"alternative-id":["S0954611121001426"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106436","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106436"}}